Paolo Ghia

Paolo Ghia

Division of Molecular Oncology, IRCCS, San Raffaele Scientific Institute

Affiliated withIRCCS, San Raffaele Scientific InstituteUniversità Vita-Salute San RaffaeleIRCCS Istituto Scientifico San Raffaele and Università Vita-Salute San Raffaele

Research Area

Biography

Paolo Ghia has not added Biography.
If you are Paolo Ghia and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2
Year
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Publication title

Cited by 3

2014
2018

Other Publications

Article
Year
Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22.

European journal of immunology| PubMed ID: 11981828

2002
Chronic B cell malignancies and bone marrow microenvironment.

Seminars in cancer biology| PubMed ID: 12027587

2002
2002
2003
2003
2002
2003
2003
IL-12 regulates an endothelial cell-lymphocyte network: effect on metalloproteinase-9 production.

Journal of immunology (Baltimore, Md. : 1950)| PubMed ID: 14500672

2003
2004
2004
The nature and origin of the B-chronic lymphocytic leukemia cell: a tentative model.

Hematology/oncology clinics of North America| PubMed ID: 15325702

2004
2005
2004
2005
Diagnostic criteria for monoclonal B-cell lymphocytosis.

British journal of haematology| PubMed ID: 16042682

2005
2005
The origin of B-cell chronic lymphocytic leukemia.

Seminars in oncology| PubMed ID: 16616061

2006
2006
2006
2007
Chronic lymphocytic leukemia.

Critical reviews in oncology/hematology| PubMed ID: 17544290

2007
The normal counterpart to the chronic lymphocytic leukemia B cell.

Best practice & research. Clinical haematology| PubMed ID: 17707828

2007
A woman and her canary: a tale of chlamydiae and lymphomas.

Journal of the National Cancer Institute| PubMed ID: 17848672

2007
2008
Overview of monoclonal B-cell lymphocytosis.

British journal of haematology| PubMed ID: 18021084

2007
2007
2007
2008
Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 18662968

2008
2009
2009
2009
B-cell clones as early markers for chronic lymphocytic leukemia.

The New England journal of medicine| PubMed ID: 19213679

2009
2009
Monoclonal B lymphocytosis in the general population.

Leukemia & lymphoma| PubMed ID: 19347732

2009
2009
2009
2010
2010
2010
2010
2010
CLL-like monoclonal B-cell lymphocytosis: are we all bound to have it?

Seminars in cancer biology| PubMed ID: 20816789

2010
2010
2010
Monoclonal B cell lymphocytosis in hepatitis C virus infected individuals.

Cytometry. Part B, Clinical cytometry| PubMed ID: 20839339

2010
2010
Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 21189302

2011
2011
2011
2011
2011
2011
2011
2012
2012
KIBRA gene methylation is associated with unfavorable biological prognostic parameters in chronic lymphocytic leukemia.

Epigenetics : official journal of the DNA Methylation Society| PubMed ID: 22430796

2012
2012
2012
2012
2012
In vitro sensitivity of CLL cells to fludarabine may be modulated by the stimulation of Toll-like receptors.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 23224401

2013
A look into the future: can minimal residual disease guide therapy and predict prognosis in chronic lymphocytic leukemia?

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program| PubMed ID: 23233566

2012
2013
2013
MBL versus CLL: how important is the distinction?

Hematology/oncology clinics of North America| PubMed ID: 23561472

2013
2013
2013
Loss of function of Ribonuclease T2, an ancient and phylogenetically conserved RNase, plays a crucial role in ovarian tumorigenesis.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 23630276

2013
Antigen selection in B-cell lymphomas--tracing the evidence.

Seminars in cancer biology| PubMed ID: 23932942

2013
Monoclonal B cell lymphocytosis and "in situ" lymphoma.

Seminars in cancer biology| PubMed ID: 23999128

2014
2013
IgG-switched CLL has a distinct immunogenetic signature from the common MD variant: ontogenetic implications.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 24240110

2014
2014
2014
Idelalisib and rituximab in relapsed chronic lymphocytic leukemia.

The New England journal of medicine| PubMed ID: 24450857

2014
2014
2014
2014
2014
Management of chronic lymphocytic leukemia.

Haematologica| PubMed ID: 24881042

2014
2014
2014
2014
2014
Ibrutinib: better combined with other drugs?

The Lancet. Oncology| PubMed ID: 25150799

2014
2015
Targeting Hedgehog in haematological malignancies.

The Lancet. Haematology| PubMed ID: 26688482

2015
2016
A new life for rituximab?

The Lancet. Haematology| PubMed ID: 26947197

2016
2014
2016
Ibrutinib holds promise for patients with 17p deletion CLL.

The Lancet. Oncology| PubMed ID: 27637986

2016
2016
2017
2017
2018
2018
2018
Monoclonal B-cell lymphocytosis: Does the elderly patient need a specialistic approach?

European journal of internal medicine| PubMed ID: 30268574

2018
2018